Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
View analytic
Tuesday, June 20 • 4:00pm - 5:15pm
#287: Patient-Reported Outcomes (PROs): Hot Topics - Part 2 of 2

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-17-558-L04-P; CME 1.25; IACET 1.25; RN 1.25

Patient-reported outcomes (PROs)are not new. The FDA released a final guidance on this topic in 2009, and there have been many presentations and discussions on the evidence and measurement principles used to guide development of fit-for-purpose PRO assessments. This session will move the conversation from basic PRO development to discuss the latest hot topics regarding PROs in drug development. Hot topics might include (but are not limited to): FDA's flexibility in implementing principles in the guidance; methods to evaluate meaningful change on PRO assessments; strategies for incorporating PRO endpoints into multiplicity-adjusted endpoint hierarchy with traditional endpoints; novel methods to validate new PRO tools).

Learning Objectives

Summarize practical insights and methods that can be used to facilitate the development and use of PROs in clinical trials.

Chair

Dennis Revicki, PhD

Speaker

Developing and Evaluating PRO Instruments in Clinical Trials: Risks and Advantages for Applications Using Registration Trials
Dennis Revicki, PhD

Developing and Evaluating PRO Instruments in Clinical Trials: Overview and Importance of Key Psychometric Characteristics
Wen-Hung Chen, PhD

Developing and Evaluating PRO Instruments in Clinical Trials: Statistical Issues for Applications Using Registration Trials
Lisa A. Kammerman, PhD, MS

Panelist
Laura Lee Johnson, PhD



Moderators
DR

Dennis Revicki

Senior Vice President, and Executive Director, COE for Outcomes Research, Evidera
Dennis Revicki, PhD is a Senior Vice President, Outcomes Research, Evidera, Bethesda, MD, USA. He has over 30 years experience in patient-reported outcome development and psychometric evaluation, clinical trial methods and analysis, developing patient-reported outcome assessment... Read More →

Speakers
WC

Wen-Hung Chen

Social Science Analyst, Office of New Drugs, CDER, FDA
Wen-Hung Chen is a reviewer in the Clinical Outcome Assessment Staff in the Office of New Drugs, Center for Drug Evaluation and Research, FDA. Dr. Chen’s responsibility includes supporting the review divisions in issues related to the development and interpretation of study end... Read More →
LL

Laura Lee Johnson

Deputy Director, Office of Biostatistics, DB III, OTS, CDER, FDA
Dr. Laura Lee Johnson is the patient focused drug development liaison for the Office of Biostatistics at the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research. She co-directs the NIH Principles and Practice of Clinical Research course. Prior to working... Read More →
LK

Lisa Kammerman

Senior Statistical Science Director, AstraZeneca
Lisa Kammerman, PhD is a Senior Statistical Director in Oncology at AstraZeneca. She consults on PRO projects and regulatory submissions. She developed AZ's PRO guidance document and led AZ's missing data project. After 24 years of public service, she retired from the FDA, where... Read More →
DR

Dennis Revicki

Senior Vice President, and Executive Director, COE for Outcomes Research, Evidera
Dennis Revicki, PhD is a Senior Vice President, Outcomes Research, Evidera, Bethesda, MD, USA. He has over 30 years experience in patient-reported outcome development and psychometric evaluation, clinical trial methods and analysis, developing patient-reported outcome assessment... Read More →


Tuesday June 20, 2017 4:00pm - 5:15pm
S404d McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616